trypsinogen and Pituitary-Neoplasms

trypsinogen has been researched along with Pituitary-Neoplasms* in 2 studies

Other Studies

2 other study(ies) available for trypsinogen and Pituitary-Neoplasms

ArticleYear
In vitro mutagenesis of trypsinogen: role of the amino terminus in intracellular protein targeting to secretory granules.
    The Journal of cell biology, 1987, Volume: 105, Issue:2

    The mouse anterior pituitary tumor cell line, AtT-20, targets secretory proteins into two distinct intracellular pathways. When the DNA that encodes trypsinogen is introduced into AtT-20 cells, the protein is sorted into the regulated secretory pathway as efficiently as the endogenous peptide hormone ACTH. In this study we have used double-label immunoelectron microscopy to demonstrate that trypsinogen colocalizes in the same secretory granules as ACTH. In vitro mutagenesis was used to test whether the information for targeting trypsinogen to the secretory granules resides at the amino (NH2) terminus of the protein. Mutations were made in the DNA that encodes trypsinogen, and the mutant proteins were expressed in AtT-20 cells to determine whether intracellular targeting could be altered. Replacing the trypsinogen signal peptide with that of the kappa-immunoglobulin light chain, a constitutively secreted protein, does not alter targeting to the regulated secretory pathway. In addition, deletion of the NH2-terminal "pro" sequence of trypsinogen has virtually no effect on protein targeting. However, this deletion does affect the signal peptidase cleavage site, and as a result the enzymatic activity of the truncated trypsin protein is abolished. We conclude that neither the signal peptide nor the 12 NH2-terminal amino acids of trypsinogen are essential for sorting to the regulated secretory pathway of AtT-20 cells.

    Topics: Adrenocorticotropic Hormone; Amino Acid Sequence; Animals; Cell Line; Cytoplasmic Granules; DNA, Recombinant; Mice; Mutation; Pituitary Neoplasms; Protein Processing, Post-Translational; Transformation, Genetic; Trypsinogen

1987
The exocrine protein trypsinogen is targeted into the secretory granules of an endocrine cell line: studies by gene transfer.
    The Journal of cell biology, 1985, Volume: 101, Issue:2

    The exocrine protein rat anionic trypsinogen has been expressed and is secreted from the murine anterior pituitary tumor cell line AtT-20. We examined which secretory pathway trypsinogen takes to the surface of this endocrine-derived cell line. The "constitutive" pathway externalizes proteins rapidly and in the absence of an external stimulus. In the alternate, "regulated" pathway, proteins are stored in secretory granules until the cells are stimulated to secrete with 8-Br-cAMP. On the basis of indirect immunofluorescence localization, stimulation of release, and subcellular fractionation, we find that trypsinogen is targeted into the regulated secretory pathway in AtT-20 cells. In contrast, laminin, an endogenous secretory glycoprotein, is shown to be secreted constitutively. Thus it appears that the transport apparatus for the regulated secretory pathway in endocrine cells can recognize not only endocrine prohormones, but also the exocrine protein trypsinogen, which suggests that a similar sorting mechanism is used by endocrine and exocrine cells.

    Topics: Adrenocorticotropic Hormone; Animals; Base Sequence; Cell Line; Cytoplasmic Granules; Exocrine Glands; Mice; Pituitary Gland, Anterior; Pituitary Neoplasms; Plasmids; Protein Processing, Post-Translational; Rats; Transfection; Trypsinogen

1985